BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2946562)

  • 1. Effect of naltrexone on apnea of prematurity and on plasma beta-endorphin-like immunoreactivity.
    MacDonald MG; Moss IR; Kefale GG; Ginzburg HM; Fink RJ; Chin L
    Dev Pharmacol Ther; 1986; 9(5):301-9. PubMed ID: 2946562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid and plasma beta-endorphin-like immunoreactivity in full-term neonates and in preterm neonates with and without apnea of prematurity.
    MacDonald MG; Herman BH; Kammerman LA; Bors Z; Arthur-Smith A
    Dev Pharmacol Ther; 1990; 15(1):8-15. PubMed ID: 2242711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-endorphin concentration and xanthine treatment in apnea of prematurity.
    Sankaran K; Hindmarsh KW; Tan L; Kalapurackal M
    Clin Invest Med; 1993 Jun; 16(3):197-203. PubMed ID: 8365047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone therapy of apnea in children with elevated cerebrospinal fluid beta-endorphin.
    Myer EC; Morris DL; Brase DA; Dewey WL; Zimmerman AW
    Ann Neurol; 1990 Jan; 27(1):75-80. PubMed ID: 2137320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma beta-endorphin concentration in infants with apneic spells.
    Sankaran K; Hindmarsh KW; Watson VG
    Am J Perinatol; 1984 Jul; 1(4):331-4. PubMed ID: 6097281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiorespiratory depression and plasma beta-endorphin levels in low-birth-weight infants during the first day of life.
    Davidson S; Gil-Ad I; Rogovin H; Laron Z; Reisner SH
    Am J Dis Child; 1987 Feb; 141(2):145-8. PubMed ID: 2949599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid and plasma beta-endorphin concentrations in prolonged infant apnea (near-miss sudden infant death syndrome).
    Sankaran K; Hindmarsh KW; Wallace SM; McKay RJ; O'Donnell M
    Dev Pharmacol Ther; 1986; 9(4):224-30. PubMed ID: 2944729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts.
    Kosten TR; Kreek MJ; Ragunath J; Kleber HD
    Life Sci; 1986 Jul; 39(1):55-9. PubMed ID: 2941636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of stress and stress-therapy on plasma beta-endorphin-like immunoreactivity.
    Laorden ML; Miralles F; Fuentes T; López F; Canteras M
    Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):671-4. PubMed ID: 6099457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma beta-endorphin in neonates: effect of prematurity, gender, and respiratory status.
    Leuschen MP; Willett LD; Bolam DL; Nelson RM
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1062-6. PubMed ID: 1939520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity.
    Lemyre B; Davis PG; De Paoli AG
    Cochrane Database Syst Rev; 2000; (3):CD002272. PubMed ID: 10908544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of medication, pain and progress in labour on plasma beta-endorphin-like immunoreactivity.
    Thomas TA; Fletcher JE; Hill RG
    Br J Anaesth; 1982 Apr; 54(4):401-8. PubMed ID: 6279134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome.
    Myer EC; Morris DL; Adams ML; Brase DA; Dewey WL
    J Pediatr; 1987 Nov; 111(5):660-6. PubMed ID: 2959762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
    Recant L; Voyles NR; Luciano M; Pert CB
    Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate addiction and plasma beta-endorphin-like immunoreactivity: methadone maintained, recently detoxified and early naltrexone treated ex-addicts.
    Cushman P; Morris D; Adams M; Dewey W
    Alcohol Drug Res; 1987; 7(5-6):533-40. PubMed ID: 2956960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory distress and beta-endorphin-like immunoreactivity in humans.
    Yanagida H; Corssen G
    Anesthesiology; 1981 Nov; 55(5):515-9. PubMed ID: 6271027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of beta-endorphin in respiratory disorders in man.
    Dewey W; Morris D; Brase D; Myer E
    NIDA Res Monogr; 1988; 81():181-7. PubMed ID: 2970012
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorphins in infant apnea.
    Orlowski JP
    N Engl J Med; 1982 Jul; 307(3):186-7. PubMed ID: 6283348
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in plasma beta-endorphin-like immunoreactivity at parturition in normal women.
    Pilkington JW; Nemeroff CB; Mason GA; Prange AJ
    Am J Obstet Gynecol; 1983 Jan; 145(1):111-3. PubMed ID: 6295162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.